Zhang et al. pointed out that inhibiting the SAA1 gene could down-regulate the AKT signaling pathway and promote glioblastoma cell apoptosis, and SAA1 could be used as a potential therapeutic target and prognostic index of glioblastoma (Tokunaga et al., 2018). The gene discussed is AKT1; the disease is glioblastoma.